Volume 10, Issue 4 (Jul-Aug 2016 2016)                   mljgoums 2016, 10(4): 9-11 | Back to browse issues page


XML Print


1- Department of Clinical Biochemistry, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
2- Department of Clinical Biochemistry, Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
3- Department of Internal Medicine, Gastroenterology and Hepatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4- Department of Medical Physiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran , hosseinansari62@gmail.com
Abstract:   (12234 Views)

ABSTRACT

       Background and Objective: Esophageal cancer is the third most common type of cancer in Iran. Studies on water, soil, grains, waste and sediments in Golestan Province have shown that the environmental concentrations of antimony and strontium are increased in areas with high incidence rate for cancer. The carcinogenic effects of strontium have been reported, but carcinogenicity of antimony is still unclear. Since there is not enough information regarding the relationship between the concentration of strontium and antimony and prevalence of esophageal cancer in the province, this study aimed to evaluate serum levels of these elements in patients with esophageal cancer using atomic absorption spectroscopy.

       Methods: This study was performed on 30 patients with esophageal squamous cell carcinoma and 30 healthy matched controls. After sampling, concentrations of strontium and antimony were measured using atomic absorption spectroscopy.

       Results: Half of the esophageal cancer patients and control participants were male. The mean age of patients and controls was 66 ± 13 and 64 ± 8 years, respectively. The mean serum concentration of strontium in patients and controls was 24.18 ± 1.62 and 24.08 ± 1.46 μg/L, respectively. The mean serum concentration of antimony in patients and controls was 18.61 ± 1.48 and 18.98 ± 1.93 μg/L, respectively. No statistically significant difference was observed between the serum concentrations of the two elements in patients and controls.

        Conclusion: There is no difference between serum levels of strontium and antimony in cancer patients and healthy controls, which could be due to tissue accumulation.

          Keywords: Antimony, Strontium, Esophageal Neoplasms.

Full-Text [PDF 581 kb]   (1955 Downloads)    
Research Article: Original Paper |
Received: 2016/10/26 | Accepted: 2016/10/26 | Published: 2016/10/26 | ePublished: 2016/10/26

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.